<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03736707</url>
  </required_header>
  <id_info>
    <org_study_id>NARDS</org_study_id>
    <nct_id>NCT03736707</nct_id>
  </id_info>
  <brief_title>Selective High Frequency Oscillatory Ventilation (HFOV) for Neonates</brief_title>
  <official_title>Elective High Frequency Oscillatory Ventilation (HFOV) Versus Conventional Mechanical Ventilation(CMV) for Acute Respiratory Distress Syndrome(ARDS) and/or Respiratory Distress Syndrome(RDS) in Neonates：a Multicenter Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jiulongpo No.1 People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chongqing Maternal and Child Health Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Anhui Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children’s Hospital of The Capital Institute of Pediatrics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Hospital of Tsinghua University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Women and Children's Hospital, Branch of Chongqing Sanxia Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Quanzhou Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xiamen Maternity &amp; Child Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhujiang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangdong Academy of Medical Science and General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangdong Women and Children Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Women and Children’s Health Hospital of Yulin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Women and Children Health Care Hospitalof GuangXi Zhuang Autonomous</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Affiliated Hospital of Guangzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guiyang Maternal and Child Health Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zunyi First People's Hospital</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Hospital of Lanzhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gansu Provincial Maternity and Child-Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>LanZhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Harbin Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Xinjiang Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhengzhou Children's Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Third Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>the Maternal and Child Health Hospital of Hainan Province</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bethune International Peace Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan Union Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children’s Hospital of Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maternal and Children’s Healthcare Hospital of Taian</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Hospital of Shandong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanxi Provincial Maternity and Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chengdu Women and Children's Center Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital Of Southwest Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Affiliated Hospital of Southwest Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shenzhen People’s Hospital, The Second Medical College of Jinan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Central Hospital of Gynecology Obstetrics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>People's Hospital of Xinjiang Uygur Autonomous Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kunming Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First People's Hospital of Yunnan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Kunming Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yan’an Hospital Affiliated to Kunming Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Women and Children’s Health Hospital of Qujing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The People's Hospital of Dehong Autonomous Prefecture</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yinchuan No 1 people’s Hospital Affiliated of Ningxia Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Children's Hospital of Zhejiang University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Women's Hospital School Of Medicine Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing 302 Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hunan Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Women and Children Hospital of Qinghai Province</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jiangxi Province Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Inner Mongolia People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mianyang Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>People's Liberation Army No.202 Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ningbo Women &amp; Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Children's Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Guangxi Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xianyang children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Qinhuangdao Maternal and Child Health Care Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xuzhou Children Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Daping Hospital and the Research Institute of Surgery of the Third Military Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neonatal respiratory distress syndrome (RDS) remains a major respiratory disorder for the
      increasing preterm population, and its incidence has been confirmed to be increased gradually
      with decreased gestational age. Previous studies demonstrated incidences of 90% at 24 weeks',
      80% at 28 weeks', 57% at 30-31 weeks', and 25% at 35-36 weeks' gestational age(GA). However,
      these figures were mainly performed in the pre-neonatal acute respiratory distress syndrome
      (ARDS) era, in which ARDS was usually considered as RDS, and surfactant was therefore used
      repeatedly. In fact, no studies have indicated beneficial effects of surfactant for adult and
      pediatric ARDS, and therefore, its exact action for neonatal ARDS was needed to be further
      elucidated. In 2017, the international ARDS collaborative group provided the first consensus
      definition for neonatal ARDS, and the exact incidence of neonatal ARDS and mortality were
      unknown.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Similarities to adult and pediatric ARDS, no special pharmacologic therapy for neonatal ARDS
      has been shown to reduce either short-term or long-term mortality and morbidity, the risk of
      death therefore remains high for preterm infants. Study reported that 50% chance of death
      with neonatal intensive care appeared at 24 weeks in most high-income countries and 34 in
      low-income and middle-income countries. Among the survivors, bronchopulmonary dysplasia(BPD),
      neurologic impairment and retinopathy of prematurity(ROP) were the main causes of secondary
      death, rehospitalization and medical resource use. How to reduce rate of mortality and severe
      complications constitutes a challenge for neonatologists.

      An interesting result was that HFOV did reduce the incidence of mortality as compared with
      CMV(2:9 vs 3:3, 95%confidence intervel(CI) 0.09-0.89, P=0.03) (4:177 vs 13:179, 95%CI
      0.10-0.94, P=0.04). The results suggested that, excluding preterm infants with RDS, HFOV
      could also reduce other primary outcomes, such as the risk of death, BPD, IVH and neurologic
      impairment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">December 12, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 12, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Neonates will be randomized and assigned either to selective HFOV or CMV</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>death</measure>
    <time_frame>36 weeks' gestational age</time_frame>
    <description>the included neonates were dead</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the incidence of extracorporeal membrane oxygenation(ECMO) for neonates in group 2</measure>
    <time_frame>36 weeks' gestational age</time_frame>
    <description>the included neonates need to being supported by ECMO</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the incidence of bronchopulmonary dysplasia(BPD)</measure>
    <time_frame>36 weeks' gestational age</time_frame>
    <description>the included neonates were diagnosed with BPD</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the incidence of retinopathy of prematurity(ROP)</measure>
    <time_frame>36 weeks' gestational age</time_frame>
    <description>the included neonates were diagnosed with ROP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the incidence of necrotizing enterocolitis(NEC)</measure>
    <time_frame>36 weeks' gestational age</time_frame>
    <description>the included neonates were diagnosed with NEC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of invasive ventilation</measure>
    <time_frame>36 weeks' gestational age</time_frame>
    <description>duration of invasive ventilation for HFOV or CMV</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>air leak (pneumothorax and/or pneumomediastinum) occurred</measure>
    <time_frame>36 weeks' gestational age</time_frame>
    <description>the included neonates were diagnosed with air leak</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intraventricular hemorrhage(IVH)&gt;2nd grade</measure>
    <time_frame>36 weeks' gestational age</time_frame>
    <description>the included neonates were diagnosed with IVH&gt;2nd grade</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>composite mortality/BPD</measure>
    <time_frame>36 weeks' gestational age</time_frame>
    <description>the included neonates were diagnosed with composite mortality/BPD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the success rate of extubation</measure>
    <time_frame>36 weeks' gestational age</time_frame>
    <description>the included neonates wean from invasive ventilation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">646</enrollment>
  <condition>Respiratory Distress Syndrome</condition>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <condition>High Frequency Oscillatory Ventilation</condition>
  <arm_group>
    <arm_group_label>Selective HFOV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Selective HFOV will be provided</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CMV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CMV will be provided</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Selective HFOV</intervention_name>
    <description>Selective HFOV will only be provided with piston/membrane oscillators able to provide a real oscillatory pressure with active expiratory phase</description>
    <arm_group_label>Selective HFOV</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CMV</intervention_name>
    <description>CMV was delivered by time-cycled, pressure-limited ventilators</description>
    <arm_group_label>CMV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        subgroup 1: For a neonate to be included, the following four criteria must be fulfilled:

          1. gestational age (GA) between 26+0 and 33+6 weeks (estimated on the postmenstrual date
             and early gestation ultrasonographic findings);

          2. birth weight less than 2000g;

          3. diagnosis with ARDS and/or RDS;

          4. assisted with CMV within 12 h after birth;

          5. stabilization before randomization within 12 h after birth: FiO2&lt;0.40, Paw&lt;12 cmH2O,
             90%-95% of SpO2, pH&gt;7.20, PaCO2&lt;60 mmHg(these may be evaluated by arterial blood gas
             analysis).

        subgroup 2 For a neonate to be included, the following four criteria must be fulfilled:

          1. gestational age (GA) more than 33+6 weeks (estimated on the postmenstrual date and
             early gestation ultrasonographic findings);

          2. birth weight more than 2000g;

          3. diagnosis with ARDS and/or RDS;

          4. assisted with CMV within 12 h after birth;

          5. stabilization before randomization within 12 h after birth: FiO2&lt;0.40, Paw&lt;12 cmH2O,
             90%-95% of SpO2, pH&gt;7.20, PaCO2&lt;60 mmHg(these may be evaluated by arterial blood gas
             analysis).

        Exclusion Criteria:

        Neonates with at least one of the following criteria are not eligible for the study:

          1. neonates who only needed noninvasive ventilation;

          2. major congenital anomalies or chromosomal abnormalities;

          3. neuromuscular diseases;

          4. upper respiratory tract abnormalities;

          5. need for surgery known before the first extubation;

          6. grade Ⅲ-IV-intraventricular hemorrhage (IVH);

          7. congenital lung diseases or malformations or pulmonary hypoplasia.

          8. parents reject to join
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Children's Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400042</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shi Yuan, PhD,MD</last_name>
      <phone>13508300283</phone>
      <phone_ext>86</phone_ext>
      <email>petshi530@vip.163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>November 7, 2018</study_first_submitted>
  <study_first_submitted_qc>November 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2018</study_first_posted>
  <last_update_submitted>January 7, 2020</last_update_submitted>
  <last_update_submitted_qc>January 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital of Chongqing Medical University</investigator_affiliation>
    <investigator_full_name>Chen Long,MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

